288 filings
Page 7 of 15
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
12 Nov 20
Departure of Directors or Certain Officers
4:05pm
10-Q
2020 Q3
ALNAQ
Allena Pharmaceuticals, Inc.
Quarterly report
9 Nov 20
8:02am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
9 Nov 20
Allena Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
8:00am
4
ALNAQ
Allena Pharmaceuticals, Inc.
6 Oct 20
Allena Pharmaceuticals / Ann Calby Miller ownership change
6:02pm
3
ALNAQ
Allena Pharmaceuticals, Inc.
6 Oct 20
Allena Pharmaceuticals / Ann Calby Miller ownership change
6:00pm
DEFA14A
ALNAQ
Allena Pharmaceuticals, Inc.
5 Oct 20
Additional proxy soliciting materials
4:20pm
DEF 14A
ALNAQ
Allena Pharmaceuticals, Inc.
Definitive proxy
5 Oct 20
4:16pm
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
5 Oct 20
Allena Pharmaceuticals Appoints Ann Miller, M.D. to its Board of Directors
4:06pm
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
1 Oct 20
Allena Pharmaceuticals Announces $25 Million Strategic Convertible Debt Financing Agreement
8:15am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
28 Aug 20
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:16pm
10-Q
2020 Q2
ALNAQ
Allena Pharmaceuticals, Inc.
Quarterly report
5 Aug 20
8:01am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
5 Aug 20
Allena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
8:00am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
29 Jul 20
Allena Pharmaceuticals Announces $5.0 Million Bought Deal Offering
4:12pm
424B5
ALNAQ
Allena Pharmaceuticals, Inc.
29 Jul 20
Prospectus supplement for primary offering
4:07pm
FWP
ALNAQ
Allena Pharmaceuticals, Inc.
27 Jul 20
Free writing prospectus
9:31pm
FWP
ALNAQ
Allena Pharmaceuticals, Inc.
27 Jul 20
Free writing prospectus
5:02pm
424B5
ALNAQ
Allena Pharmaceuticals, Inc.
27 Jul 20
Prospectus supplement for primary offering
4:59pm
SC 13G
ALNAQ
Allena Pharmaceuticals, Inc.
9 Jun 20
Allena Pharmaceuticals / Empery Asset Management ownership change
11:23am
8-K
ALNAQ
Allena Pharmaceuticals, Inc.
5 Jun 20
Allena Pharmaceuticals Announces $15.0 Million Registered Direct Offering PricedAt-the-Market under Nasdaq Rules
12:54pm
424B5
ALNAQ
Allena Pharmaceuticals, Inc.
5 Jun 20
Prospectus supplement for primary offering
12:48pm